Baltimore, MD, United States of America

Dong Shen

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Dong Shen: A Pioneer in mRNA Vaccine Development

Introduction: Dong Shen, an inventive mind based in Baltimore, MD, has made significant strides in the field of biotechnology, particularly in the development of mRNA vaccines. His innovative research contributes to the fight against viral infections, specifically the novel coronavirus.

Latest Patents: Dong Shen holds a patent titled "Composition and method of mRNA vaccines against novel coronavirus infection." This groundbreaking patent provides compositions and methods for potent mRNA vaccines aimed at preventing and treating 2019-nCoV infections. The patented composition includes a pharmaceutical framework comprising one or more mRNA molecules that encode spike protein epitopes, including mutated variants, in addition to mRNA cocktails that target essential viral genes. These are formulated with pharmaceutically acceptable polymeric nanoparticle carriers and liposomal nanoparticle carriers. The patent also outlines methods for stimulating systemic immune responses and administering treatments, which can be delivered via subcutaneous, intraperitoneal, and intramuscular injections.

Career Highlights: Shen is a key contributor at Rnaimmune, Inc., where he applies his expertise in mRNA technologies. His work demonstrates a commitment to innovative solutions in addressing global health challenges. His patent is a testament to his dedication to advancing vaccine technology and improving public health outcomes.

Collaborations: Throughout his career, Dong Shen has worked alongside talented individuals, including colleagues Shenggao Tang and Chun Lu. These collaborations enhance the innovative processes integral to their research and development efforts in mRNA vaccine technology.

Conclusion: Dong Shen’s contributions to the realm of biotechnology, encapsulated in his pioneering patent on mRNA vaccines, reinforce the importance of innovation in combating infectious diseases. His work at Rnaimmune, Inc. and collaborations with fellow researchers mark significant advancements in the fight against viral infections, underscoring the vital role that inventors play in modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…